General SurgeryNMC Grounded

Breast Cancer: TNM Staging, Molecular Subtypes & Surgical Management

Bailey & Love's Short Practice of Surgery 28th Ed · Ch 53 The Breast

Verified Clinical DiagramBailey & Love's Short Practice of Surgery 28th Ed · Ch 53 The Breast

High-Yield Clinical Pearls & Exam Keys

Core Needle Biopsy (Tru-cut) is the diagnostic procedure of choice for breast masses because it preserves tissue architecture to demonstrate basement membrane invasion and allows immunohistochemistry for ER, PR, and HER2.

Sentinel Lymph Node Biopsy (SLNB) using radiotracer (Technetium-99m sulfur colloid) and blue dye avoids unnecessary axillary dissection in clinically node-negative (cN0) patients.

Breast Conserving Surgery (BCS / lumpectomy with wide margins) combined with postoperative whole-breast radiotherapy yields equivalent overall survival to Modified Radical Mastectomy (MRM).

Ask Dr. Medarro about General Surgery

Instant NMC-grounded answers with standard textbook citations

AI Senior Mentor

Or tap a high-yield exam question:

The Golden Rule: Triple Assessment of Breast Lumps

Key #1

1. Clinical Examination (Bilateral breast, axillary and supraclavicular lymph node palpation)

Key #2

2. Imaging (Bilateral Mammography for women ≥ 40 years; High-Resolution Ultrasound for women < 40 years)

Key #3

3. Pathology (Core Needle Biopsy; FNAC cannot distinguish in situ from invasive carcinoma or assess ER/PR/HER2)

Molecular Subtypes of Breast Carcinoma

Molecular Subtype	Receptor Status Profile	Targeted Therapy & Prognosis
Luminal A	ER+, PR+ (high ≥20%), HER2-neu negative, low Ki-67 (<14%)	Endocrine therapy (Tamoxifen / Aromatase Inhibitors); Best overall prognosis
HER2-Enriched	ER negative, PR negative, HER2-neu 3+ (amplified)	Anti-HER2 targeted therapy (Trastuzumab / Pertuzumab); High recurrence if untreated
Triple-Negative (TNBC / Basal-like)	ER negative, PR negative, HER2-neu negative (often BRCA1 associated)	Systemic cytotoxic chemotherapy + Immunotherapy (Pembrolizumab); Aggressive, early visceral relapse

Interactive Clinical Vignette Practice

Live Rule-Out Engine

Case Vignette #1NEET-PG Calibrated

A 52-year-old postmenopausal woman undergoes screening mammography, revealing a 1.8 cm spiculated mass in the upper outer quadrant of the right breast with microcalcifications. Physical examination shows no palpable axillary lymph nodes. Core needle biopsy confirms Invasive Ductal Carcinoma (Grade 2, ER positive, PR positive, HER2 negative). What surgical option offers equivalent overall survival to total mastectomy while preserving the breast?

ASimple lumpectomy without margin assessment or radiation

BWide local excision (lumpectomy) with negative margins + Sentinel Lymph Node Biopsy + Postoperative Whole-Breast Radiotherapy

CImmediate radical Halsted mastectomy including pectoralis major excision

DPrimary high-dose systemic chemotherapy followed by watchful observation

Comprehensive Clinical & Pathophysiological Breakdown

**1. Epidemiological Profile & Molecular Subtypes** Breast cancer is the most common malignant neoplasm and the leading cause of cancer mortality among women worldwide. Molecular classification dictates systemic therapy: * **Luminal A**: ER+, PR+, HER2-, low Ki-67 (<14%). Excellent prognosis, highly responsive to endocrine therapy. * **Luminal B**: ER+, PR+ or -, HER2+ or -, high Ki-67 (>14%). Moderately responsive to endocrine therapy and chemotherapy. * **HER2-Enriched**: ER-, PR-, HER2 amplified. Highly responsive to HER2-targeted monoclonal antibodies (Trastuzumab, Pertuzumab). * **Triple-Negative (Basal-Like)**: ER-, PR-, HER2-. Highly aggressive, poor prognosis, responsive only to cytotoxic chemotherapy, immunotherapy (anti-PD-L1), and PARP inhibitors in BRCA carriers. **2. The Gold Standard: Triple Assessment** Any patient presenting with a breast lump must undergo systematic **Triple Assessment**, achieving >99% diagnostic accuracy when all three components concord: 1. **Clinical Examination**: Careful bilateral palpation of breasts, chest wall, and regional nodal basins (axillary, supraclavicular). Malignant features: hard, irregular, painless, fixed lump, skin tethering, peau d'orange (cutaneous lymphatic permeation), nipple retraction, bloody discharge. 2. **Imaging**: - *Bilateral Digital Mammography* (Craniocaudal and Mediolateral Oblique views): Method of choice in women $\ge$ 40 years. Malignant signs: clustered microcalcifications, spiculation, architectural distortion. - *High-Resolution Breast Ultrasound*: Method of choice in women <40 years (dense fibro-glandular tissue); differentiates solid from cystic lesions and guides biopsy. - *BI-RADS Classification*: Categorized from 0 (incomplete) to 6 (biopsy-proven malignancy). 3. **Histopathology (Core Needle Biopsy)**: - **Core Needle Biopsy (14-gauge) is the diagnostic method of choice**. Yields architectural tissue architecture, distinguishes In Situ from Invasive carcinoma, and enables IHC testing for ER, PR, HER2, and Ki-67. - *FNAC is obsolete as a sole diagnostic test* because it cannot differentiate in situ from invasive carcinoma and cannot reliably assess HER2 status. **3. TNM Staging Summary (AJCC 8th Edition)** * **T (Primary Tumor)**: - T1: $\le$ 2 cm (T1a: >0.1 to 0.5 cm; T1b: >0.5 to 1 cm; T1c: >1 to 2 cm). - T2: >2 cm to $\le$ 5 cm. - T3: >5 cm. - T4: Any size with direct extension to chest wall (T4a) or skin ulceration/satellite nodules (T4b); T4c: both 4a and 4b; T4d: **Inflammatory breast cancer**. * **N (Regional Lymph Nodes)**: - N1: Movable ipsilateral Level I/II axillary nodes. - N2: Fixed/matted ipsilateral axillary nodes or internal mammary nodes. - N3: Ipsilateral infraclavicular, supraclavicular, or combined internal mammary and axillary nodes. * **M (Distant Metastasis)**: M0: No metastasis; M1: Distant metastasis present (most common sites: Bone > Lung > Liver > Brain). **4. 🔬 Surgical & Multimodal Management Protocols** * **Early Breast Cancer (Stage I, IIA, select IIB)**: - *Breast-Conserving Surgery (BCS)*: Wide local excision / Lumpectomy with clear histological margins (no ink on tumor) **MANDATORILY followed by whole-breast adjuvant radiation therapy**. - *Modified Radical Mastectomy (MRM, Auchincloss or Patey)*: Removal of entire breast tissue including nipple-areola complex and pectoralis major fascia, with Level I and II axillary lymph node dissection. Indicated if multifocal disease, contraindications to radiation, or patient preference. * **Sentinel Lymph Node Biopsy (SLNB)**: Method of choice for axillary staging in clinically node-negative (cN0) patients using blue dye (Patent Blue V) and radiocolloid (Technetium-99m sulfur colloid). Spares node-negative patients the morbidity of full axillary dissection (lymphedema). * **Systemic Adjuvant / Neoadjuvant Therapy**: - *Endocrine Therapy*: 5–10 years of **Tamoxifen** (Selective ER Modulator) in premenopausal women; **Aromatase Inhibitors** (Letrozole, Anastrozole) in postmenopausal women. - *HER2-Targeted Therapy*: Trastuzumab (Herceptin) for 1 year in all HER2+ tumors. - *Chemotherapy*: Anthracycline and taxane-based regimens (AC followed by Paclitaxel) for triple-negative, node-positive, or high-risk tumors. **5. 📖 Standard Textbook Reference** * *Bailey & Love's Short Practice of Surgery*, 28th Ed., Ch. 52: The Breast, pp. 886–914. * *NCCN Clinical Practice Guidelines in Oncology: Breast Cancer*, Version 2.2024.

Viva Examiner Traps & Model Answers

Oral Exam Prep

What anatomical nerves are at risk of injury during Axillary Lymph Node Dissection?

1. Long Thoracic Nerve of Bell (supplies Serratus Anterior; injury causes winged scapula). 2. Thoracodorsal Nerve (supplies Latissimus Dorsi; injury impairs shoulder adduction/internal rotation). 3. Intercostobrachial Nerve (sensory to upper inner arm; injury causes numbness).

What are the absolute contraindications to Breast Conserving Surgery (BCS)?

1. Multi-centric disease in separate quadrants. 2. Diffuse malignant-appearing microcalcifications on mammogram. 3. Prior therapeutic radiotherapy to the breast/chest wall. 4. Persistent positive surgical margins despite re-excision. 5. First/second trimester pregnancy.

What is the Nottingham Histologic Score (Elston-Ellis modification of Bloom-Richardson)?

It grades breast carcinoma (Grade 1-3) based on three parameters scored 1-3 each: Tubule and gland formation, Nuclear pleomorphism, and Mitotic count.

Additional Exam Practice Vignettes (1)

Case Vignette #2

Following a right modified radical mastectomy and level II axillary dissection for invasive breast cancer, a 46-year-old woman notes difficulty pushing heavy doors and brushing her hair. On examination, when she pushes forward against a wall with outstretched hands, the vertebral border of her right scapula projects prominently backward. Which nerve was injured?

Injury to the Long Thoracic Nerve (roots C5, C6, C7) causes paralysis of the Serratus Anterior muscle, leading to the classic 'winged scapula' deformity on pushing against resistance.

Free Student Account Required

Unlock Complete Viva Traps & Additional Case Vignettes

Access model examiner answers, comprehensive rule-out breakdowns, and 4K spotter explanations.

Use email and password instead

Free student account•No credit card required

Medarro Study Hub

Want 50+ Clinical Vignettes & 4K 3D Spotters on General Surgery?

Practice Spaced Repetition Decathlon, generate instant 7-day adaptive study plans, and upload your college PDFs into the personal vault.

Related High-Yield Chapters

Acute Appendicitis Hypovolemic Shock Intestinal Obstruction